Isabella Chen

Isabella Chen is an experienced project manager in the biomedical and clinical research sectors, currently serving as Project Manager at Silence Therapeutics plc since January 2022. Prior experience includes roles as Research Project Manager at bit.bio, where responsibilities encompassed leading research projects in CRISPR gene-editing, and as Clinical Research Project Manager at Cancer Research UK, where project leadership extended to oncology trials and the effects of COVID-19 on clinical outcomes. Earlier positions include Assistant Clinical Project Manager at Hammersmith Medicines Research Ltd, Developmental Neurobiology Research Assistant at the Okinawa Institute of Science and Technology, and various roles in clinical trial administration. Isabella holds an MSc in Regenerative Medicine from The University of Edinburgh and a BSc in Biomedical Science from Royal Holloway, University of London.